Apogee Therapeutics Stock (NASDAQ: APGE) stock price, news, charts, stock research, profile.
Open | $46.170 |
Close | $47.130 |
Volume / Avg. | 238.494K / 695.495K |
Day Range | 44.520 - 47.465 |
52 Wk Range | 14.190 - 72.290 |
Market Cap | $2.659B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 12.04% |
Days to Cover | 7.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apogee Therapeutics (NASDAQ: APGE) through any online brokerage.
Other companies in Apogee Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX) and Arrowhead Pharma (NASDAQ:ARWR).
The latest price target for Apogee Therapeutics (NASDAQ: APGE) was reported by Jefferies on Wednesday, March 6, 2024. The analyst firm set a price target for 75.00 expecting APGE to rise to within 12 months (a possible 59.13% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Apogee Therapeutics (NASDAQ: APGE) is $47.13 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Apogee Therapeutics.
Apogee Therapeutics’s Q1 earnings are confirmed for Saturday, May 11, 2024.
There is no upcoming split for Apogee Therapeutics.
Apogee Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.